Bone Therapeutics updates data for osteoarthritic knee pain drug clinical trials

BELGIUM – Bone Therapeutics has provided data update for its ongoing clinical studies on enhanced viscosupplement, JTA-004, targeting osteoarthritic knee pain. The JTA-004 Phase III clinical study, having achieved target patient recruitment in December 2020, has now completed the six-month follow-up in all patients. Bone Therapeutics expects to report topline results for the 3-month primary endpoint and 6-month follow-up data in the first half of September 2021. JTA-004 Phase III study is a controlled, randomized, double-blind trial. It is evaluating the potential of a single, intra-articular injection of JTA-004 to…

Read More